FUNCTIONAL OUTCOME OF PATIENTS WITH CHRONIC PLANTAR FASCIITIS TREATED BY LOCAL INJECTION OF AUTOLOGOUS PLATELET-RICH PLASMA

Author:

RAJESH KUMAR KANOJI ,PRADEEP KUMAR SUTHAR ,HIMANSHU

Abstract

Objectives: The objectives of the study are as follows: To assess functional outcome of patients with chronic plantar fasciitis (PF) treated by autologous injection of platelet-rich plasma (PRP). (1) To know the side effects, if any, in these patients. Methods: This was a prospective study conducted in the Department of orthopedics of a tertiary care medical college. Forty patients having chronic PF were included in this study on the basis of a predefined inclusion and exclusion criteria. Autologous PRP was injected in plantar fascia at the point of maximum tenderness. Patients were followed up for 3 months. Intensity of pain and functional outcome was assessed using the visual analog score (VAS) score and American Orthopedic Foot and Ankle Score (AOFAS) score. For statistical purposes, p<0.05 was taken as significant. Results: There were 14 (35.00%) males and 26 (65.00%) females with a M: F ratio of 1:1.85. The mean age of male and female patients was found to be 43.82±9.98 years and 41.68±10.12 years, respectively. Majority of the patients (65%) were overweight whereas 6 (15%) patients were obese and 8 (20%) patients were having a normal healthy body mass index. The mean duration of symptoms was found to be 10.67±3.89 months. The mean VAS score at the time of final follow-up was significantly less (0.96±0.46) as compared to pre-injection VAS score (7.20±1.38) whereas the AOFAS score at the time of final follow-up (91.9±6.68) significantly improved as compared to pre-injection AOFAS score (38.96±8.78). There were no major side effects in any of the studied cases. Conclusion: Local injection of autologous PRP appears to be an effective treatment for chronic PF in terms of reduction of pain and functional improvement with no significant side effects.

Publisher

Innovare Academic Sciences Pvt Ltd

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3